These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 723825

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Juvenile dermatomyositis-associated calcinosis successfully treated with combined immunosuppressive, bisphosphonate, oral baricitinib and physical therapy.
    Agud-Dios M, Arroyo-Andres J, Rubio-Muñiz C, Zarco-Olivo C, Calleja-Algarra A, de Inocencio J, Perez SIP.
    Dermatol Ther; 2022 Dec; 35(12):e15960. PubMed ID: 36286617
    [No Abstract] [Full Text] [Related]

  • 23. An update on juvenile dermatomyositis.
    Boccaletti V, Di Nuzzo S, Feliciani C, Fabrizi G, Pagliarello C.
    G Ital Dermatol Venereol; 2014 Oct; 149(5):519-24. PubMed ID: 25034096
    [Abstract] [Full Text] [Related]

  • 24. Juvenile dermatomyositis in north India.
    Singh S, Kumar L, Shankar KR.
    Indian Pediatr; 1997 Mar; 34(3):193-8. PubMed ID: 9282485
    [Abstract] [Full Text] [Related]

  • 25. Results of the German ESPED-recording of new patients with juvenile dermatomyositis (JDM).
    Dressler F, Frosch M, Mönkemöller K, Thon A, Weissbarth-Riedel E, Horneff G.
    Klin Padiatr; 2011 Sep; 223(5):280-2. PubMed ID: 21509712
    [Abstract] [Full Text] [Related]

  • 26. Amyopathic dermatomyositis presenting as skin necrosis.
    Veetil BM, Whitt I.
    J Clin Rheumatol; 2011 Sep; 17(6):332-3. PubMed ID: 21869704
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Severe adult dermatomyositis with unusual calcinosis.
    Garel B, Barète S, Rigolet A, Le Pelletier F, Benveniste O, Hervier B.
    Rheumatology (Oxford); 2015 Nov; 54(11):2024. PubMed ID: 26286744
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Universalis Calcinosis in Adult Dermatomyositis: An "Anti-NXP2 Syndrome".
    Fodil D, Meyer A, Salah SS, Sibilia J, Attal N, Tafiani-Lefkir S.
    J Clin Rheumatol; 2016 Oct; 22(7):387-9. PubMed ID: 27660942
    [No Abstract] [Full Text] [Related]

  • 33. [Dermatopolymyositis: evaluation of 63 patients].
    Marchiori PE, Hirata MT, Scaff M, de Oliveira RM, Cossermelli W, Levy JA, de Assis JL.
    Arq Neuropsiquiatr; 1987 Jun; 45(2):137-42. PubMed ID: 3426420
    [Abstract] [Full Text] [Related]

  • 34. [The polymyositis-dermatomyositis complex: current studies of the etiopathogenesis and notes on therapy].
    Sacerdoti G, Fasano A, Noferi A, Altucci P.
    Clin Ter; 1981 Jun 30; 97(6):631-51. PubMed ID: 7023806
    [No Abstract] [Full Text] [Related]

  • 35. Combined immunosuppressive therapy in steroid-resistant, chronic glomerular diseases of childhood.
    Campbell RA, Jacinto EY.
    J Lancet; 1967 May 30; 87(5):149-56 passim. PubMed ID: 6043891
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Dermatomyositis-polymyositis in infancy].
    Mendilaharzu F, Gianantonio CA, Pena I, Nolasco AM.
    Bol Med Hosp Infant Mex; 1979 May 30; 36(6):1003-24. PubMed ID: 385015
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Juvenile Dermatomyositis].
    Keller S, Golsari A, Yamamura J.
    Rofo; 2018 Sep 30; 190(9):810-813. PubMed ID: 29698985
    [No Abstract] [Full Text] [Related]

  • 40. Dermatomyositis and polymyositis update on current controversies.
    Callen JP.
    Australas J Dermatol; 1987 Aug 30; 28(2):62-7. PubMed ID: 3452311
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.